{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Who are in the management team of Abivax SA?
As of March 2022, the management team of Abivax SA includes Dr. Philippe Pouletty (Chairman), Ms. Joy Amundson, Dr. Claude Bertrand, Mr. Jean-Jacques Bertrand, Mr. Jerome Gallot, and Mr. Antoine Pau, who oversee the company's strategic direction and governance.
What does Abivax SA do?
Abivax SA is a clinical stage biopharmaceutical company focused on developing novel anti-viral compounds and therapeutic vaccines for severe infectious diseases, with a market cap of EUR 340.65 million. It currently has no earnings or dividends and significant negative return on equity.
How big is Abivax SA?
As of Jun 19, Abivax SA has a market capitalization of 340.65 million, classifying it as a Micro Cap company. There is no valid financial data available for net sales or net profit for the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
